CA-TRACKFORCE-VALIANT
29.6.2022 16:02:08 CEST | Business Wire | Press release
Trackforce Valiant , a leading provider of security workforce management solutions, today announced the acquisition of TrackTik Software , one of the most innovative and fastest growing cloud-based security workforce management providers. The combination of these two companies has created a new dominant market leader in providing visibility and control for the physical security workforce.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220629005064/en/
“We are very excited to welcome TrackTik into the Trackforce Valiant family,” said Trevor Campion, CEO of Trackforce Valiant. “Now more than ever, we believe in the importance of providing the right security solutions for companies of all sizes and business needs. The addition of TrackTik enables us to provide a wide range of technology options that are purpose-built for the unique needs of physical security operations.”
TrackTik was founded in 2013 with the mission of providing a complete set of tools through easy-to-use software and taking the fear out of technology in order to put it to work for security workforce management. From their origins in Montreal, Canada, TrackTik provides solutions to over 35 countries across 6 continents and has been steadily innovating the way companies leverage workforce technology for security operations. The platform provides a full suite of applications, combining the needs of back-office administration to front line security operations.
As a result of this new venture, physical security companies now can leverage the combined best practices of two leading security workforce management providers, providing multiple options for how they can manage security operations. Additionally, the combined technology teams of Trackforce Valiant and TrackTik Software will enable the company to further innovate and enhance their solutions further than any other software provider in the industry.
“The physical security market continues to grow, and with that so does the need for solutions that can grow with them,” said Simon Ferragne, CEO of TrackTik. “This acquisition positions us as the dominant leader for security workforce technology, and we are thrilled to work together to continue our mission to build innovative, leading-edge solutions for our customers.”
Both companies will continue to maintain operations in service of their customers and partners, with Trevor Campion overseeing the combined organization as CEO, and Simon Ferragne, TrackTik’s CEO, entering the role of CTO. Simon Ferragne and TrackTik’s investors, CDPQ Investissements, Georgian, Klass Capital, Inovia Capital, Intercap, and Schauer Ventures have reinvested a portion of their proceeds in the newly combined entity to help foster continued growth in the company. TrackTik will continue to operate and maintain its presence in Quebec as one of Canada’s top small and medium employers. Trackforce Valiant and TrackTik will collaborate on developing and innovating security solutions that include Time and Labor Management, Guard Touring, Incident Management, Dispatch and Mobile Patrol, as well as Billing and Payroll management.
About Trackforce Valiant
Trackforce Valiant is a leader in complete security workforce management solutions. More than 300,000 professionals at over 30,000 customer sites in 45 countries use Trackforce Valiant every day to ensure the delivery of reliable security services, improve operational efficiency and optimally manage their human capital. For nearly 30 years, Trackforce Valiant has provided fully integrated security solutions to its partners and customers. Thanks to its security expertise and state-of-the-art information systems technology, Trackforce Valiant proudly offers the most effective solutions available on the market. Clients include the world's leading security guard service providers, as well as major airports, universities, and corporations across the globe. Additional information is available at https://www.trackforcevaliant.com .
About TrackTik
Founded in 2013, TrackTik is a privately-owned, VC-backed Canadian scale-up of 200+ employees providing a cloud-based workforce management solution in the physical security industry. Headquartered in Montreal, with offices in the UK and a presence in various provinces in Canada and the Netherlands, TrackTik serves 780 customers in more than 35 countries. TrackTik quickly established itself as a market leader with the mission to seamlessly connect humans, workflows, and systems to deliver a better way of working to the physical security workforce. TrackTik’s integrated suite of automated tools fluidly connects frontline operations and back-office management allowing managers to follow the progression of field workers, reduce manual tasks, lower cost, glean actionable insights from data to demonstrate value, promote operational efficiency and boost productivity, job satisfaction, and retention. Additional information is available at https://www.tracktik.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220629005064/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
